Fundz

Find Therapeutics Inc. raised CAD$10 million in a Series A Extension from investors CTI Life Sciences, Investissement Québec and adMare BioInnovations to advance its clinical pipeline.

PRIVATEJan 09, 2026

Amount Raised

C$10 Million

Round Type

Series A

MontrealBiotechnologyHealth Care

Investors

adMare BioInnovationsInvestissement QuébecCTI Life Sciences

Description

Find Therapeutics Inc. has closed its Series A Extension Round of CAD$10 million from current investors. The financing will support Phase 2-readiness activities for its lead drug candidate tasronetide. This funding demonstrates investor confidence in Find's mission and progress.

Quick answer

Find Therapeutics raised C$10 Million in a Series A round, dated January 9, 2026. Investors: adMare BioInnovations, Investissement Québec and CTI Life Sciences. Find Therapeutics is based in Montreal, Quebec, Canada.

How much did Find Therapeutics raise?
Find Therapeutics raised C$10 Million in a Series A round on January 9, 2026.
Who invested in Find Therapeutics?
adMare BioInnovations, Investissement Québec and CTI Life Sciences are named as investors in this round.
What does Find Therapeutics do?
Find Therapeutics is a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases.
Where is Find Therapeutics based and how big is it?
Find Therapeutics is based in Montreal, Quebec, Canada. Fundz records about 10 employees.
Who are the decision-makers at Find Therapeutics?
Fundz holds 2 contacts at Find Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Find Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Oncare raised $3M (Series A) on February 23, 2026.
  • QSTEM raised $1.5M (Seed) on February 20, 2026.
  • Lario Therapeutics raised $2.4M (Grant) on February 19, 2026.
  • Epetōme raised an undisclosed amount on February 19, 2026.
  • Altesa raised $75M (Series B) on February 19, 2026.
  • Elumn8 Medical raised an undisclosed amount (Series C) on February 18, 2026.

Who to call at Find Therapeutics, and when

A new round usually means Find Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Find Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Find Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Find Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Find Therapeutics

Location

Montreal, Quebec, Canada

About

Find Therapeutics is a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases. The company was launched in 2020 and is dedicated to the development of next generation therapies to treat inflammatory autoimmune diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Find Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Find Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Find Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.